Investigational Study With the BD PosiFlush™ SafeScrub on NADs
← catalyst calendarSponsored by Becton, Dickinson and Company (industry) · BDX — their whole pipeline →.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · None · Basic science
Enrollment
222actual
Sites
2
Country
Austria
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-10-22 | actual | When the study began enrolling |
| Primary completion | 2026-04-30 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-04-30 | actual | The whole study's end, after follow-up |
| First posted | 2024-09-19 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-01 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- CRBSI - Catheter Related Bloodstream Infection
Interventions
- Device: BD PosiFlush™ SafeScrub
- Device: BD PosiFlush™
Primary outcome
what the primary-completion date above is the date OFDevice related adverse events
measured 15 minutes
Permalink · BDX's whole pipeline · Catalyst calendar · Every registered study · What changed